Mixed (combined) phenotype of the late stage of age-related macular degeneration
https://doi.org/10.21516/2072-0076-2021-14-2-69-75
Abstract
With multimodal visualization of the chorioretinal complex structures using modern research methods, it was possible to isolatea mixed, or combined, phenotype of the late stage of age-related macular degeneration (AMD). Early detection of this AMD form is of vital importance not only for accurate diagnosis, but for choosing optimal management tactics for patients. The paper presents two clinical cases with different variants of the development of the mixed phenotype of the late AMD stage. In one case, the long-lasting “geographic atrophy” (GA) was complicated by the development of choroidal neovascularization, while in the other case GA appeared during the treatment of wetAMD.
About the Authors
N. V. Neroeva
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Natalia V. Neroeva— Cand. of Med. Sci., ophthalmologist, department of retinal and optic nerve pathology
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
V. V. Neroev
Helmholtz National Medical Research Center of Eye Diseases; A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Vladimir V. Neroev— Academician of RAS, Dr. of Med. Sci., professor, director, head of eye diseases chair of the faculty of additional professional education
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
20, Bldg.1, Delegatskaya St., Moscow, 127473
M. V. Ryabina
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Marina V. Ryabina — Cand. of Med. Sci., senior researcher, department of retinal and optic nerve pathology
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
A. G. Karmokova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Asiyat G. Karmokova — PhD, department of retinal and optic nerve
pathology
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
O. A. Losanova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Oksana A. Losanova— PhD, department of retinal and optic nerve
pathology
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
References
1. Wong W.L., Su X., Li X., et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2 (2): 106–16. doi: 10.1016/S2214-109X(13)70145-1
2. Klein R., Klein B.E, Linton K.L.Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992; 99 (6): 933–43. doi:10.1016/s0161-6420(92)31871-8
3. Lim L.S., Mitchell P., Seddon J.M., Holz F.G., Wong T.Y.Age-related macular degeneration. Lancet. 2012; 379 (9827): 1728–38. doi: 10.1016/S0140-6736(12)60282-7
4. Klein R., Klein B.E., Knudtson M.D., et al.Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2007; 114 (2): 253–62. doi: 10.1016/j.ophtha.2006.10.040
5. Holz F.G., Strauss E.C., Schmitz-Valckenberg S., van Lookeren Campagne M.Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014;121 (5): 1079–91.doi: 10.1016/j.ophtha.2013.11.023
6. Xu L., Blonska A.M., Pumariega N.M., et al. Reticular macular disease is associated with multilobular geographic atrophy in age-related macular degeneration. Retina. 2013; 33 (9): 1850–62. doi: 10.1097 / IAE.0b013e31828991b2
7. Marsiglia M., Boddu S., Bearelly S., et al. Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration. Invest. Ophthalmol. Vis Sci. 2013; 54 (12): 7362–9. doi:10.1167/iovs.12-11073
8. Veritti D., Sarao V., Lanzetta P.Neovascular age-related macular degeneration. Ophthalmologica. 2012; 227 (1): 11–20. doi: 10.1159/000337154
9. Mitchell P., Smith W., Attebo K., Wang J.J.Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995; 102 (10): 1450–60. doi: 10.1016/s0161-6420(95)30846-9
10. Kaszubski P., Ben Ami T., Saade C., Smith R.T. Geographic atrophy and choroidal neovascularization in the same eye: a review. Ophthalmic Res. 2016; 55 (4): 185–93. doi: 10.1159/000443209
11. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 1976; 60 (5): 324–41. doi: 10.1136/ bjo.60.5.324
12. Lorenz E.Zimmerman lecture. Ophthalmology. 1993; 100 (10): 1519–35. doi:10.1016/s0161-6420(93)31466-1
13. Chakravarthy U., Wong T.Y., Fletcher A., et al. Clinical risk factors for agerelated macular degeneration: a systematic review and meta-analysis. BMC Ophthalmology. 2010; 10 (31). doi: 10.1186 / 1471-2415-10-31
14. Grob S., Luo J., Hughes G., et al. Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization. Eye (Lond). 2012; 26 (8): 1106–13. doi:10.1038/eye.2012.107
15. Tomany S.C., Wang J.J., Van Leeuwen R., et al.Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004; 111 (7): 1280–7. doi:10.1016 / j.ophtha.2003.11.010
16. Pumariega N.M., Smith R.T., Sohrab M.A., Letien V., Souied E.H.A prospective study of reticular macular disease. Ophthalmology. 2011; 118 (8): 1619–25. doi:10.1016/j.ophtha.2011.01.029
17. Complications of Age-related Macular Degeneration Prevention Trial Research Group. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. Ophthalmology. 2008; 115 (9): 1474–9. doi: 10.1016/j.ophtha.2008.03.008
18. Clemons T.E., Milton R.C., Klein R., et al.Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005; 112 (4): 533–9. doi:10.1016/j.ophtha.2004.10.047
19. Klein R., Peto T., Bird A., Vannewkirk M.R. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 2004; 137 (3): 486–95. doi: 10.1016/j.ajo.2003.11.069
20. Francis P.J., George S., Schultz D.W., et al.The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered. 2007; 63 (3–4): 212–8. doi: 10.1159/000100046
21. Xu L., Mrejen S., Jung J.J., et al.Geographic atrophy in patients receiving antivascular endothelial growth factor for neovascular age-related macular degeneration. Retina. 2015; 35 (2): 176–86. doi: 10.1097/IAE.0000000000000374
22. Saade C., Ganti B., Marmor M., Freund K.B., Smith R.T. Risk characteristics of the combined geographic atrophy and choroidal neovascularisation phenotype in age-related macular degeneration. Br. J. Ophthalmol. 2014; 98 (12): 1729–32. doi: 10.1136/bjophthalmol-2014-305005
23. Sunness J.S., Gonzalez-Baron J., Bressler N.M., Hawkins B., Applegate C.A.The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999; 106 (5): 910–9. doi: 10.1016/S0161-6420(99)00509-6
24. Klein R., Meuer S.M., Knudtson M.D., Klein B.E. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am. J. Ophthalmol. 2008; 146 (5): 692–9. doi:10.1016/j.ajo.2008.05.050
25. Ferrington D.A., Kapphahn R.J., Leary M.M., et al.Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration. Exp. Eye Res. 2016; 145: 269–77. doi: 10.1016/j.exer.2016.01.018
26. Efendieva M.H., Budzinskaya M.V., Kadyshev V.V., et al.Molecular and genetic aspects of age-related macular degeneration and glaucoma. Vestnik oftal'mologii. 2019; 135 (3): 121–7 (in Russian)]. https://doi.org/10.17116/oftalma2019135031121
27. Muether P.S., Neuhann I., Buhl C., et al. Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration. Retina. 2013; 33 (9): 1809–14. doi:10.1097/IAE.0b013e318285cd9e
28. Neroev V.V., Slepova O.S., Rjabina M.V., Karapetjan L.V. The change of VEGF content in the tear fluid and blood serum of patients with the wet form of age macular degeneration treated by Lucentis. Russian ophthalmological journal. 2013; 6 (3): 62–5 (in Russian)].
29. Amaro M.H., Roller A.B. Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy. Arq. Bras. Oftalmol. 2012; 75 (4): 273–6. doi: 10.1590/s0004-27492012000400011
30. Querques G., Massamba N., Coscas F., Forte R., Souied E.H.Choroidal neovascularisation complicating geographic atrophy in age-related macular degeneration. Br. J. Ophthalmol. 2012; 96 (12): 1479–83. doi: 10.1159/000443209
Review
For citations:
Neroeva N.V., Neroev V.V., Ryabina M.V., Karmokova A.G., Losanova O.A. Mixed (combined) phenotype of the late stage of age-related macular degeneration. Russian Ophthalmological Journal. 2021;14(2):69-75. (In Russ.) https://doi.org/10.21516/2072-0076-2021-14-2-69-75
Views:
886
Email this article 